There are 2789 resources available
1383P - Phase I study of the irreversible FGFR inhibitor futibatinib in Japanese patients with advanced solid tumors: Updated dose expansion results and activity in gastric cancer
Presenter: Yasutoshi Kuboki
Session: ePoster Display
1384P - DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial
Presenter: Samuel Klempner
Session: ePoster Display
1385P - Phase II study of neoadjuvant camrelizumab combined with chemoradiation for locally advanced proximal gastric cancer (Neo-PLANET, NCT03631615)
Presenter: Zhao-qing Tang
Session: ePoster Display
1388P - Efficacy of second line immunotherapy in advanced upper gastrointestinal tract malignancies: A pooled analysis of randomized clinical trials
Presenter: Panagiotis Ntellas
Session: ePoster Display
1391P - Clinical progress in inoperable or recurrent advanced gastric cancer treatment from 1,004 single institute experiences between 2007 and 2018
Presenter: Izuma Nakayama
Session: ePoster Display
1392P - Submucosal versus subserosal approaches toward optimized indocyanine green tracer-guided lymphadenectomy for gastric cancer: A randomized clinical trial
Presenter: Qi-Yue Chen
Session: ePoster Display